Harris A. Ahmad

P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis

BACKGROUND: Ozanimod, an oral sphingosine 1-phosphate (S1P) receptor modulator that selectively targets S1P 1 and S1P ...

Raymond Cross , MD;

Jonathan Calkwood ;

Ashwini Pai ;

Millie D. Long , MD, MPH;

Ayanbola Elegbe ;

James Sheffield ;

Douglas Wolf ;

Adil Javed ;

AnnKatrin Petersen ;

Marc Pondel ;

Lorna Charles ;

Harris A. Ahmad ;

12/15/2021

Outcomes of Early Versus Delayed Advanced Therapy Among Patients With Moderate Ulcerative Colitis in the United States: TARGET-IBD

1 University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, United States; 2 University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United St...

Miguel D. Regueiro , MD;

Harris A. Ahmad ;

Derek Gazis ;

Edward L. Barnes ;

Heather L. Morris ;

Marla C. Dubinsky , MD;

Julie M. Crawford ;

David T. Rubin , MD;

Megan Lutz ;

Shweta Shah ;

01/11/2024

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

October 29 ⁠–⁠ November 2

November 1 ⁠–⁠ November 2

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8

November 8 ⁠–⁠ November 10

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

See Full Calendar

Harris A. Ahmad

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products